Place des biomarqueurs dans le dépistage du SAHOS. Une revue narrative de la littérature
Gespeichert in:
| Titel: | Place des biomarqueurs dans le dépistage du SAHOS. Une revue narrative de la littérature |
|---|---|
| Autoren: | Hauquiert, B, Drion, Emilie, Deflandre, Eric |
| Weitere Verfasser: | UCL - (SLuc) Service d'anesthésiologie |
| Quelle: | Revue des maladies respiratoires, Vol. 38, no.5, p. 455-465 (2021) |
| Verlagsinformationen: | Elsevier BV, 2021. |
| Publikationsjahr: | 2021 |
| Schlagwörter: | Pulmonary and Respiratory Medicine, Anesthésie & soins intensifs, Syndrome d'apnées et d'hypopnées obstructives du sommeil, Polysomnography, Sciences de la santé humaine, Cardiovascular System, Dépistage de masse, 03 medical and health sciences, 0302 clinical medicine, Neurologie, Humans, Human health sciences, Biomarqueurs, Sleep Apnea, Obstructive, Mass screening, Médecine personnalisée, Sleep Apnea, Obstructive/diagnosis, Sleep Apnea, Obstructive/complications, Anesthesia & intensive care, Obstructive sleep apnea, Personalized medicine, 3. Good health, Neurology, Hypertension, Sleep Apnea, Obstructive/epidemiology, Biomarkers |
| Beschreibung: | Obstructive sleep apnoea (OSA) is a common sleep-related breath disorder associated with cardiovascular and cerebrovascular complications, such as hypertension, arrhythmia, coronary artery disease and stroke. Unfortunately, OSA is underdiagnosed.Because of its clinical and therapeutic variability, OSA could benefit a personalized medicine approach. Diagnosis with polysomnography is expensive and access is limited. Clinical scoring systems allow screening of OSA, but many limitations exist. Because of this, biomarkers could be useful for the detection of OSA.Biomarkers specific to OSA would allow for better mass screening and more personalized treatment of the disease. This narrative review of the literature aims to summarize the biomarkers already described for the diagnosis of OSA and clarify both their advantages and limitations in daily practice.Our review of the literature did not actually identify an ideal biomarker even if promising research is ongoing. |
| Publikationsart: | Article |
| Sprache: | French |
| ISSN: | 0761-8425 |
| DOI: | 10.1016/j.rmr.2021.04.005 |
| Zugangs-URL: | https://pubmed.ncbi.nlm.nih.gov/33958251 https://europepmc.org/article/MED/33958251 https://www.sciencedirect.com/science/article/pii/S0761842521002229 https://pubmed.ncbi.nlm.nih.gov/33958251/ https://hdl.handle.net/2078.1/268411 |
| Rights: | Elsevier TDM |
| Dokumentencode: | edsair.doi.dedup.....40402ab5497931e78dffc6ecf8d4643b |
| Datenbank: | OpenAIRE |
Nájsť tento článok vo Web of Science | Abstract: | Obstructive sleep apnoea (OSA) is a common sleep-related breath disorder associated with cardiovascular and cerebrovascular complications, such as hypertension, arrhythmia, coronary artery disease and stroke. Unfortunately, OSA is underdiagnosed.Because of its clinical and therapeutic variability, OSA could benefit a personalized medicine approach. Diagnosis with polysomnography is expensive and access is limited. Clinical scoring systems allow screening of OSA, but many limitations exist. Because of this, biomarkers could be useful for the detection of OSA.Biomarkers specific to OSA would allow for better mass screening and more personalized treatment of the disease. This narrative review of the literature aims to summarize the biomarkers already described for the diagnosis of OSA and clarify both their advantages and limitations in daily practice.Our review of the literature did not actually identify an ideal biomarker even if promising research is ongoing. |
|---|---|
| ISSN: | 07618425 |
| DOI: | 10.1016/j.rmr.2021.04.005 |